Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis
BackgroundThe survival of early placement (within 72h after admission) of transjugular intrahepatic portosystemic shunts (early-TIPS) in patients with cirrhosis and acute variceal bleeding (AVB) is controversial.ObjectivesWe performed a systemic review and meta-analysis to assess whether early-TIPS...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00603/full |
_version_ | 1818178486578184192 |
---|---|
author | Shuang Li Chao Zhang Lu-Lu Lin Qi Wang Hong-Xia Zuo Ai-Ling Zhan Jie Luo Yu-Ming Niu Guo-Qing Zhong |
author_facet | Shuang Li Chao Zhang Lu-Lu Lin Qi Wang Hong-Xia Zuo Ai-Ling Zhan Jie Luo Yu-Ming Niu Guo-Qing Zhong |
author_sort | Shuang Li |
collection | DOAJ |
description | BackgroundThe survival of early placement (within 72h after admission) of transjugular intrahepatic portosystemic shunts (early-TIPS) in patients with cirrhosis and acute variceal bleeding (AVB) is controversial.ObjectivesWe performed a systemic review and meta-analysis to assess whether early-TIPS could improve survival in patients with cirrhosis and acute variceal bleeding.MethodsA systematic search of the literature was conducted in PubMed, EMBASE, and Cochrane Library published before 25 June 2019 for eligible studies that compared early-TIPS with a combination of endoscopic variceal ligation (EVL) and pharmacotherapy in the therapeutic effect in AVB patients.ResultsA total of five studies with 1,754 participants were enrolled. The early-TIPS demonstrated a significant improvement in prevention of treatment failure (OR=0.11,95%CI=0.05-0.23), 6-weeks mortality (OR=0.24,95%CI=0.13-0.46), rebleeding within 6 weeks (OR=0.21,95%CI=0.12-0.36), rebleeding within 1 year (OR=0.16,95%CI=0.07-0.36), new or worsening ascites (OR=0.33,95%CI=0.21-0.53), except in encephalopathy (OR=1.29,95%CI=0.996-1.67). For 1-year mortality, a significant prior effect was also observed in early-TIPS (OR=0.64,95%CI=0.46-0.90), and the beneficial effect in Child-Pugh C patients (OR=0.35,95%CI=0.18-0.68) was equal to Child-Pugh B patients (OR=0.34,95%CI=0.25-0.58). No difference in liver transplantation and mortality caused by liver failure was observed.ConclusionsEarly covered-TIPS could be recommended for the management of AVB patients in cirrhosis demonstrating a significant improvement in treatment failure, both short- and long-term mortality, rebleeding risk, and new or worsening ascites compared to standard therapy, especially for high-risk AVB patients. It will also apply to patients with Child-Pugh A until solutions to prevent hepatic encephalopathy in future research are found. |
first_indexed | 2024-12-11T20:48:45Z |
format | Article |
id | doaj.art-37556d544bb649f5a6a4fea2a8b9f1f9 |
institution | Directory Open Access Journal |
issn | 1663-9812 |
language | English |
last_indexed | 2024-12-11T20:48:45Z |
publishDate | 2020-05-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pharmacology |
spelling | doaj.art-37556d544bb649f5a6a4fea2a8b9f1f92022-12-22T00:51:17ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-05-011110.3389/fphar.2020.00603504105Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysisShuang Li0Chao Zhang1Lu-Lu Lin2Qi Wang3Hong-Xia Zuo4Ai-Ling Zhan5Jie Luo6Yu-Ming Niu7Guo-Qing Zhong8Center for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaCenter for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaCenter for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaCenter for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaCenter for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaDepartment of Anesthesiology, Central Hospital of Shanghai Songjiang District, Shanghai, ChinaCenter for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaCenter for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaDepartment of Obstetrical, Jining No.1 People's Hospital, Jining, ChinaBackgroundThe survival of early placement (within 72h after admission) of transjugular intrahepatic portosystemic shunts (early-TIPS) in patients with cirrhosis and acute variceal bleeding (AVB) is controversial.ObjectivesWe performed a systemic review and meta-analysis to assess whether early-TIPS could improve survival in patients with cirrhosis and acute variceal bleeding.MethodsA systematic search of the literature was conducted in PubMed, EMBASE, and Cochrane Library published before 25 June 2019 for eligible studies that compared early-TIPS with a combination of endoscopic variceal ligation (EVL) and pharmacotherapy in the therapeutic effect in AVB patients.ResultsA total of five studies with 1,754 participants were enrolled. The early-TIPS demonstrated a significant improvement in prevention of treatment failure (OR=0.11,95%CI=0.05-0.23), 6-weeks mortality (OR=0.24,95%CI=0.13-0.46), rebleeding within 6 weeks (OR=0.21,95%CI=0.12-0.36), rebleeding within 1 year (OR=0.16,95%CI=0.07-0.36), new or worsening ascites (OR=0.33,95%CI=0.21-0.53), except in encephalopathy (OR=1.29,95%CI=0.996-1.67). For 1-year mortality, a significant prior effect was also observed in early-TIPS (OR=0.64,95%CI=0.46-0.90), and the beneficial effect in Child-Pugh C patients (OR=0.35,95%CI=0.18-0.68) was equal to Child-Pugh B patients (OR=0.34,95%CI=0.25-0.58). No difference in liver transplantation and mortality caused by liver failure was observed.ConclusionsEarly covered-TIPS could be recommended for the management of AVB patients in cirrhosis demonstrating a significant improvement in treatment failure, both short- and long-term mortality, rebleeding risk, and new or worsening ascites compared to standard therapy, especially for high-risk AVB patients. It will also apply to patients with Child-Pugh A until solutions to prevent hepatic encephalopathy in future research are found.https://www.frontiersin.org/article/10.3389/fphar.2020.00603/fullacute variceal bleedingcirrhosistransjugular intrahepatic portosystemic shuntendoscopic variceal ligationmeta-analysis |
spellingShingle | Shuang Li Chao Zhang Lu-Lu Lin Qi Wang Hong-Xia Zuo Ai-Ling Zhan Jie Luo Yu-Ming Niu Guo-Qing Zhong Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis Frontiers in Pharmacology acute variceal bleeding cirrhosis transjugular intrahepatic portosystemic shunt endoscopic variceal ligation meta-analysis |
title | Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis |
title_full | Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis |
title_fullStr | Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis |
title_full_unstemmed | Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis |
title_short | Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis |
title_sort | early tips versus current standard therapy for acute variceal bleeding in cirrhosis patients a systemic review with meta analysis |
topic | acute variceal bleeding cirrhosis transjugular intrahepatic portosystemic shunt endoscopic variceal ligation meta-analysis |
url | https://www.frontiersin.org/article/10.3389/fphar.2020.00603/full |
work_keys_str_mv | AT shuangli earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis AT chaozhang earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis AT lululin earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis AT qiwang earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis AT hongxiazuo earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis AT ailingzhan earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis AT jieluo earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis AT yumingniu earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis AT guoqingzhong earlytipsversuscurrentstandardtherapyforacutevaricealbleedingincirrhosispatientsasystemicreviewwithmetaanalysis |